139 related articles for article (PubMed ID: 30063170)
21. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
[TBL] [Abstract][Full Text] [Related]
22. Comparing rates of statin therapy in eligible patients living with HIV versus uninfected patients.
Blackman AL; Pandit NS; Pincus KJ
HIV Med; 2020 Mar; 21(3):135-141. PubMed ID: 31876122
[TBL] [Abstract][Full Text] [Related]
23. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
[TBL] [Abstract][Full Text] [Related]
24. Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management.
Mancini GBJ; Gupta M; Tsigoulis M; Cannon CP; Genest J; Ray KK; Santos RD; Watts GF; Raggi P
Atherosclerosis; 2017 Aug; 263():112-118. PubMed ID: 28623740
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease.
Power TP; Ke X; Zhao Z; Bonine NG; Cziraky MJ; Grabner M; Barron JJ; Quimbo R; Vangerow B; Toth PP
Vasc Health Risk Manag; 2018; 14():23-36. PubMed ID: 29440909
[TBL] [Abstract][Full Text] [Related]
26. Cost-Effectiveness of Lipid-Lowering Treatments in Young Adults.
Kohli-Lynch CN; Bellows BK; Zhang Y; Spring B; Kazi DS; Pletcher MJ; Vittinghoff E; Allen NB; Moran AE
J Am Coll Cardiol; 2021 Nov; 78(20):1954-1964. PubMed ID: 34763772
[TBL] [Abstract][Full Text] [Related]
27. Adoption of the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline in Cardiology Practices Nationwide.
Pokharel Y; Tang F; Jones PG; Nambi V; Bittner VA; Hira RS; Nasir K; Chan PS; Maddox TM; Oetgen WJ; Heidenreich PA; Borden WB; Spertus JA; Petersen LA; Ballantyne CM; Virani SS
JAMA Cardiol; 2017 Apr; 2(4):361-369. PubMed ID: 28249067
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of the American College of Cardiology/American Heart Association statin eligibility groups, statin use, and low-density lipoprotein cholesterol control in US adults using the National Health and Nutrition Examination Survey 2011-2012.
Wong ND; Young D; Zhao Y; Nguyen H; Caballes J; Khan I; Sanchez RJ
J Clin Lipidol; 2016; 10(5):1109-18. PubMed ID: 27678427
[TBL] [Abstract][Full Text] [Related]
29. Identification of Patients with Statin Intolerance in a Managed Care Plan: A Comparison of 2 Claims-Based Algorithms.
Bellows BK; Sainski-Nguyen AM; Olsen CJ; Boklage SH; Charland S; Mitchell MP; Brixner DI
J Manag Care Spec Pharm; 2017 Sep; 23(9):926-934. PubMed ID: 28854079
[TBL] [Abstract][Full Text] [Related]
30. Residual Hypertriglyceridemia and Estimated Atherosclerotic Cardiovascular Disease Risk by Statin Use in U.S. Adults With Diabetes: National Health and Nutrition Examination Survey 2007-2014.
Fan W; Philip S; Granowitz C; Toth PP; Wong ND
Diabetes Care; 2019 Dec; 42(12):2307-2314. PubMed ID: 31575639
[TBL] [Abstract][Full Text] [Related]
31. A systematic examination of the 2013 ACC/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease.
Karmali KN; Goff DC; Ning H; Lloyd-Jones DM
J Am Coll Cardiol; 2014 Sep; 64(10):959-68. PubMed ID: 25190228
[TBL] [Abstract][Full Text] [Related]
32. ACC/AHA guidelines superior to ESC/EAS guidelines for primary prevention with statins in non-diabetic Europeans: the Copenhagen General Population Study.
Mortensen MB; Nordestgaard BG; Afzal S; Falk E
Eur Heart J; 2017 Feb; 38(8):586-594. PubMed ID: 28363217
[TBL] [Abstract][Full Text] [Related]
33. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors.
Go AS; Ambrosy AP; Kheder K; Fan D; Sung SH; Inveiss AI; Romo-LeTourneau V; Thomas SM; Koren A; Lo JC;
Am J Cardiol; 2020 Feb; 125(4):534-541. PubMed ID: 31848029
[TBL] [Abstract][Full Text] [Related]
34. Patterns and predictors of lipid-lowering therapy in patients with atherosclerotic cardiovascular disease and/or diabetes mellitus in 2014: Insights from a large US managed-care population.
Steen DL; Khan I; Becker L; Foody JM; Gorcyca K; Sanchez RJ; Giugliano RP
Clin Cardiol; 2017 Mar; 40(3):155-162. PubMed ID: 28026031
[TBL] [Abstract][Full Text] [Related]
35. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
Rosenblit PD
Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
[TBL] [Abstract][Full Text] [Related]
36. Atherosclerotic cardiovascular disease risk assessment and predictors of statin use in Filipino-American Women.
Borja-Hart N; Graff JC; Nolan VG; Wang J; Cooper-DeHoff RM; Ancheta IB
J Clin Pharm Ther; 2019 Aug; 44(4):632-639. PubMed ID: 30963623
[TBL] [Abstract][Full Text] [Related]
37. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
[TBL] [Abstract][Full Text] [Related]
38. Lipid-lowering Therapy and Goal Achievement in High-risk Patients From French General Practice.
Ferrières J; Gorcyca K; Iorga ŞR; Ansell D; Steen DL
Clin Ther; 2018 Sep; 40(9):1484-1495.e22. PubMed ID: 30126705
[TBL] [Abstract][Full Text] [Related]
39. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).
Miedema MD; Dardari ZA; Kianoush S; Virani SS; Yeboah J; Knickelbine T; Sandfort V; Rodriguez CJ; Nasir K; Blaha MJ
J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29899017
[TBL] [Abstract][Full Text] [Related]
40. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
